The Enzyme-Linked Immunosorbent Assay (ELISA) market has witnessed growth from USD XX million to USD XX million from 2017 to 2022. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Enzyme-Linked Immunosorbent Assay (ELISA) market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis, supply chain.
Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Consumer behavior analysis and market dynamics (drivers, restraints, opportunities) provides crucial information for knowing the Enzyme-Linked Immunosorbent Assay (ELISA) market.
Key players in the global Enzyme-Linked Immunosorbent Assay (ELISA) market covered in Chapter 2 and Chapter 6:
ZEUS Scientific
BioLegend
RandD Systems
Bio-Rad Laboratories
BD Biosciences
LOEWE Biochemica
Shenzhen YHLO Biotech
Thermo Fisher Scientific
Ortho Clinical Diagnostics
ALPCO
BioM?rieux
Enzo Life Sciences
EMD Millipore
In Chapter 8 and Chapter 10.3, based on types, the Enzyme-Linked Immunosorbent Assay (ELISA) market from 2017 to 2029 is primarily split into:
Direct ELISA
Indirect ELISA
Sandwich ELISA
Competitive ELISA
In Chapter 9 and Chapter 10.4, based on applications, the Enzyme-Linked Immunosorbent Assay (ELISA) market from 2017 to 2029 covers:
Vaccine Development
Immunology
Diagnostics
Toxicology
Drug Monitoring & Pharmaceutical Industry & Transplantation
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2017 -2029) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Latin America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Enzyme-Linked Immunosorbent Assay (ELISA) market, containing global revenue and CAGR. The forecast and analysis of Enzyme-Linked Immunosorbent Assay (ELISA) market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 introduces the industrial chain of Enzyme-Linked Immunosorbent Assay (ELISA). Industrial chain analysis, raw material (suppliers, price, supply and demand, market concentration rate) and downstream buyers are analyzed in this chapter.
Chapter 4 concentrates on manufacturing analysis, including cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 5 provides clear insights into market dynamics, the influence of COVID-19 in Enzyme-Linked Immunosorbent Assay (ELISA) industry, consumer behavior analysis.
Chapter 6 provides a full-scale analysis of major players in Enzyme-Linked Immunosorbent Assay (ELISA) industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 7 pays attention to the sales, revenue, price and gross margin of Enzyme-Linked Immunosorbent Assay (ELISA) in markets of different regions. The analysis on sales, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 gives a worldwide view of Enzyme-Linked Immunosorbent Assay (ELISA) market. It includes sales, revenue, price, market share and the growth rate by type.
Chapter 9 focuses on the application of Enzyme-Linked Immunosorbent Assay (ELISA), by analyzing the consumption and its growth rate of each application.
Chapter 10 prospects the whole Enzyme-Linked Immunosorbent Assay (ELISA) market, including the global sales and revenue forecast, regional forecast. It also foresees the Enzyme-Linked Immunosorbent Assay (ELISA) market by type and application.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Table of Content
1 Enzyme-Linked Immunosorbent Assay (ELISA) Market Overview
1.1 Product Overview and Scope of Enzyme-Linked Immunosorbent Assay (ELISA)
1.2 Enzyme-Linked Immunosorbent Assay (ELISA) Segment by Type
1.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales and CAGR (%) Comparison by Type (2017-2029)
1.2.2 The Market Profile of Direct ELISA
1.2.3 The Market Profile of Indirect ELISA
1.2.4 The Market Profile of Sandwich ELISA
1.2.5 The Market Profile of Competitive ELISA
1.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Segment by Application
1.3.1 Enzyme-Linked Immunosorbent Assay (ELISA) Consumption (Sales) Comparison by Application (2017-2029)
1.3.2 The Market Profile of Vaccine Development
1.3.3 The Market Profile of Immunology
1.3.4 The Market Profile of Diagnostics
1.3.5 The Market Profile of Toxicology
1.3.6 The Market Profile of Drug Monitoring & Pharmaceutical Industry & Transplantation
1.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market, Region Wise (2017-2022)
1.4.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2022)
1.4.2 United States Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.3 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.3.1 Germany Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.3.2 UK Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.3.3 France Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.3.4 Italy Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.3.5 Spain Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.3.6 Russia Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.3.7 Poland Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.4 China Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.5 Japan Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.6 India Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.7 Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.7.1 Malaysia Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.7.2 Singapore Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.7.3 Philippines Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.7.4 Indonesia Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.7.5 Thailand Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.7.6 Vietnam Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.8 Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.8.1 Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.8.2 Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.8.3 Colombia Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.9 Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.9.1 Saudi Arabia Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.9.2 United Arab Emirates Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.9.3 Turkey Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.9.4 Egypt Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.9.5 South Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.4.9.6 Nigeria Enzyme-Linked Immunosorbent Assay (ELISA) Market Status and Prospect (2017-2022)
1.5 Global Market Size of Enzyme-Linked Immunosorbent Assay (ELISA) (2017-2029)
1.5.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Status and Outlook (2017-2029)
1.5.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Status and Outlook (2017-2029)
2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Landscape by Player
2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales and Share by Player (2017-2022)
2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Market Share by Player (2017-2022)
2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Average Price by Player (2017-2022)
2.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Gross Margin by Player (2017-2022)
2.5 Enzyme-Linked Immunosorbent Assay (ELISA) Manufacturing Base Distribution, Sales Area and Product Type by Player
2.6 Enzyme-Linked Immunosorbent Assay (ELISA) Market Competitive Situation and Trends
2.6.1 Enzyme-Linked Immunosorbent Assay (ELISA) Market Concentration Rate
2.6.2 Enzyme-Linked Immunosorbent Assay (ELISA) Market Share of Top 3 and Top 6 Players
2.6.3 Mergers & Acquisitions, Expansion
3 Enzyme-Linked Immunosorbent Assay (ELISA) Upstream and Downstream Analysis
3.1 Enzyme-Linked Immunosorbent Assay (ELISA) Industrial Chain Analysis
3.2 Key Raw Materials Suppliers and Price Analysis
3.3 Key Raw Materials Supply and Demand Analysis
3.4 Manufacturing Process Analysis
3.5 Market Concentration Rate of Raw Materials
3.6 Downstream Buyers
3.7 Value Chain Status Under COVID-19
4 Enzyme-Linked Immunosorbent Assay (ELISA) Manufacturing Cost Analysis
4.1 Manufacturing Cost Structure Analysis
4.2 Enzyme-Linked Immunosorbent Assay (ELISA) Key Raw Materials Cost Analysis
4.2.1 Key Raw Materials Introduction
4.2.2 Price Trend of Key Raw Materials
4.3 Labor Cost Analysis
4.3.1 Labor Cost of Enzyme-Linked Immunosorbent Assay (ELISA) Under COVID-19
4.4 Energy Costs Analysis
4.5 R&D Costs Analysis
5 Market Dynamics
5.1 Drivers
5.2 Restraints and Challenges
5.3 Opportunities
5.3.1 Advances in Innovation and Technology for Enzyme-Linked Immunosorbent Assay (ELISA)
5.3.2 Increased Demand in Emerging Markets
5.4 Enzyme-Linked Immunosorbent Assay (ELISA) Industry Development Trends under COVID-19 Outbreak
5.4.1 Global COVID-19 Status Overview
5.4.2 Influence of COVID-19 Outbreak on Enzyme-Linked Immunosorbent Assay (ELISA) Industry Development
5.5 Consumer Behavior Analysis
6 Players Profiles
6.1 ZEUS Scientific
6.1.1 ZEUS Scientific Basic Information, Manufacturing Base, Sales Area and Competitors
6.1.2 Enzyme-Linked Immunosorbent Assay (ELISA) Product Profiles, Application and Specification
6.1.3 ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Market Performance (2017-2022)
6.1.4 ZEUS Scientific Business Overview
6.2 BioLegend
6.2.1 BioLegend Basic Information, Manufacturing Base, Sales Area and Competitors
6.2.2 Enzyme-Linked Immunosorbent Assay (ELISA) Product Profiles, Application and Specification
6.2.3 BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Market Performance (2017-2022)
6.2.4 BioLegend Business Overview
6.3 RandD Systems
6.3.1 RandD Systems Basic Information, Manufacturing Base, Sales Area and Competitors
6.3.2 Enzyme-Linked Immunosorbent Assay (ELISA) Product Profiles, Application and Specification
6.3.3 RandD Systems Enzyme-Linked Immunosorbent Assay (ELISA) Market Performance (2017-2022)
6.3.4 RandD Systems Business Overview
6.4 Bio-Rad Laboratories
6.4.1 Bio-Rad Laboratories Basic Information, Manufacturing Base, Sales Area and Competitors
6.4.2 Enzyme-Linked Immunosorbent Assay (ELISA) Product Profiles, Application and Specification
6.4.3 Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Market Performance (2017-2022)
6.4.4 Bio-Rad Laboratories Business Overview
6.5 BD Biosciences
6.5.1 BD Biosciences Basic Information, Manufacturing Base, Sales Area and Competitors
6.5.2 Enzyme-Linked Immunosorbent Assay (ELISA) Product Profiles, Application and Specification
6.5.3 BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Market Performance (2017-2022)
6.5.4 BD Biosciences Business Overview
6.6 LOEWE Biochemica
6.6.1 LOEWE Biochemica Basic Information, Manufacturing Base, Sales Area and Competitors
6.6.2 Enzyme-Linked Immunosorbent Assay (ELISA) Product Profiles, Application and Specification
6.6.3 LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Market Performance (2017-2022)
6.6.4 LOEWE Biochemica Business Overview
6.7 Shenzhen YHLO Biotech
6.7.1 Shenzhen YHLO Biotech Basic Information, Manufacturing Base, Sales Area and Competitors
6.7.2 Enzyme-Linked Immunosorbent Assay (ELISA) Product Profiles, Application and Specification
6.7.3 Shenzhen YHLO Biotech Enzyme-Linked Immunosorbent Assay (ELISA) Market Performance (2017-2022)
6.7.4 Shenzhen YHLO Biotech Business Overview
6.8 Thermo Fisher Scientific
6.8.1 Thermo Fisher Scientific Basic Information, Manufacturing Base, Sales Area and Competitors
6.8.2 Enzyme-Linked Immunosorbent Assay (ELISA) Product Profiles, Application and Specification
6.8.3 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Market Performance (2017-2022)
6.8.4 Thermo Fisher Scientific Business Overview
6.9 Ortho Clinical Diagnostics
6.9.1 Ortho Clinical Diagnostics Basic Information, Manufacturing Base, Sales Area and Competitors
6.9.2 Enzyme-Linked Immunosorbent Assay (ELISA) Product Profiles, Application and Specification
6.9.3 Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Market Performance (2017-2022)
6.9.4 Ortho Clinical Diagnostics Business Overview
6.10 ALPCO
6.10.1 ALPCO Basic Information, Manufacturing Base, Sales Area and Competitors
6.10.2 Enzyme-Linked Immunosorbent Assay (ELISA) Product Profiles, Application and Specification
6.10.3 ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Market Performance (2017-2022)
6.10.4 ALPCO Business Overview
6.11 BioM